dl1520
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
OBJECTIVE
To evaluate the antitumor efficacy of Ad-TD-RFP for human nasopharyngeal carcinoma cells (C666-1) in vitro and in vivo…
New clinical trial data on the use of the ONYX-015 adenovirus as a chemosensitizing agent indicate that further study of this…
Objective To evaluate the efficiency of cell killing and growth inhibition of oncolytic virus dl1520 on hepatic carcinoma cells…
ONYX-015 (dl1520) is an E1B 55-kilodalton protein-deficient replicating adenovirus that is currently in clinical trials as an…
It has been suggested the E1B 55 kDa mutant adenovirus dl1520 can selectively killp53-deficient human tumor cells. In this study…
An E1B gene-attenuated adenovirus ( dl1520) has been proposed to have a selective cytolytic activity in cancer cells with a…